Free Trial

TriSalus Life Sciences (TLSI) Insider Trading & Ownership

TriSalus Life Sciences logo
$4.05 +0.45 (+12.50%)
(As of 12/20/2024 05:45 PM ET)

TriSalus Life Sciences (NASDAQ:TLSI) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
32.80%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$345,189.24
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$1,443.66
Get TLSI Insider Trade Alerts

Want to know when executives and insiders are buying or selling TriSalus Life Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TLSI Insider Buying and Selling by Quarter

TriSalus Life Sciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/17/2024Equity Ab FrankeniusMajor ShareholderBuy62,972$3.97$249,998.84  
11/22/2024Mats WahlstromDirectorBuy5,000$4.55$22,750.00  
11/20/2024Mats WahlstromDirectorBuy2,040$4.16$8,486.40  
10/5/2024Bryan F CoxInsiderSell314$4.44$1,394.16  
9/12/2024Mary T SzelaCEOBuy7,520$5.20$39,104.00  
9/10/2024Mary T SzelaCEOBuy5,000$4.97$24,850.00  
8/28/2024George Kelly MartinDirectorSell9$5.50$49.50  
(Data available from 1/1/2013 forward)

TLSI Insider Trading Activity - Frequently Asked Questions

The list of insiders at TriSalus Life Sciences includes Bryan F Cox, Equity Ab Frankenius, George Kelly Martin, Mary T Szela, and Mats Wahlstrom. Learn more on insiders at TLSI.

32.80% of TriSalus Life Sciences stock is owned by insiders. Learn more on TLSI's insider holdings.

The following insiders have purchased TLSI shares in the last 24 months: Equity Ab Frankenius ($249,998.84), Mary T Szela ($63,954.00), and Mats Wahlstrom ($31,236.40).

Insiders have purchased a total of 82,532 TLSI shares in the last 24 months for a total of $345,189.24 bought.

The following insiders have sold TLSI shares in the last 24 months: Bryan F Cox ($1,394.16), and George Kelly Martin ($49.50).

Insiders have sold a total of 323 TriSalus Life Sciences shares in the last 24 months for a total of $1,443.66 sold.

TriSalus Life Sciences Key Executives

  • Ms. Mary T. Szela B.S.N. (Age 60)
    M.B.A., CEO, President & Director
    Compensation: $880.67k
    2 recent trades
  • Mr. Sean Edward Murphy (Age 71)
    CFO & Director
    Compensation: $628.75k
  • Dr. Steven C. Katz F.A.C.S. (Age 49)
    M.D., Chief Medical Officer & Chairman of Scientific Advisory Board
    Compensation: $849.89k
  • Ms. Lori Ann Santamaria
    Vice President of Operations
  • Dr. Bryan F. Cox Ph.D. (Age 62)
    Chief Scientific & Manufacturing Officer
  • Mr. James E. Young
    Senior VP of Investor Relations & Treasurer
  • Ms. Rachel Garcia
    Marketing Manager
  • Dr. Richard B. Marshak M.B.A. (Age 65)
    MBA, VMD, Senior Vice President of Corporate Development & Strategy
  • Ms. Jennifer L. Stevens J.D. (Age 63)
    Chief Regulatory Officer
    Compensation: $630k
  • Ms. Jodi Devlin (Age 62)
    President of Commercial Operations


This page (NASDAQ:TLSI) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners